Clinical trial

Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT

NCT07690306

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2026-01-13

PhaseN/A

Study timeline

Study start (actual)2026-01-13Date precision: day

Registry last updated2026-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancer (Diagnosis)unresolved

Interventions

Sponsors & collaborators

Xiangya Hospital of Central South Universitylead sponsor

Qilu Hospital of Shandong Universitycollaborator

Chinese PLA General Hospitalcollaborator

The First Affiliated Hospital of Guangzhou Medical Universitycollaborator

RenJi Hospitalcollaborator

Mapped research locations

BeijingBeijing Municipality, China2 Los AngelesCalifornia, United States1 ShanghaiShanghai Municipality, China1 GuangzhouGuangdong, China1 JinanShandong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07690306 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.